AC
RVMDW icon

Aristeia Capital’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Aristeia Capital’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03M Sell
583,615
-41,320
-7% -$80K 0.02% 261
2025
Q4 		$572K Buy
624,935
+193,996
+45% +$109K 0.01% 304
2025
Q3 		$122K Buy
430,939
+117,908
+38% +$28.6K ﹤0.01% 414
2025
Q2 		$73.5K Sell
313,031
-6,100
-2% -$905 ﹤0.01% 407
2025
Q1 		$17K Hold
319,131
– – ﹤0.01% 388
2024
Q4 		$54.3K Buy
+319,131
New +$94.4K ﹤0.01% 311

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Aristeia Capital's RVMDW Position: Q1 2026 in Review

Aristeia Capital reduced its Revolution Medicines Inc Warrant (RVMDW) stake by 6.6% in Q1 2026, selling an estimated $80K and leaving 583,615 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #261.

Aristeia Capital first reported a position in RVMDW in Q4 2024 and has held it in 6 quarters since. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

  • Aristeia Capital held 583,615 shares of Revolution Medicines Inc Warrant worth $1.03M as of Q1 2026.
  • Aristeia Capital sold 41,320 Revolution Medicines Inc Warrant shares in Q1 2026, an estimated $80K.
  • Revolution Medicines Inc Warrant made up 0.02% of Aristeia Capital's portfolio in Q1 2026, its #261 holding.
  • Aristeia Capital first reported a position in Revolution Medicines Inc Warrant in Q4 2024 and has held it in 6 quarters since.
  • 23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on Aristeia Capital's 13F filing for Q1 2026, filed 15 May 2026.